William Blair Investment Management
TXG icon

William Blair Investment Management’s 10x Genomics TXG Stock Holding History

William Blair Investment Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,066,422
Closed -$159M – 455
2021
Q4 		$159M Sell
1,066,422
-43,464
-4% -$6.66M 0.43% 83
2021
Q3 		$162M Sell
1,109,886
-16,321
-1% -$2.8M 0.46% 76
2021
Q2 		$221M Sell
1,126,207
-23,539
-2% -$4.26M 0.69% 47
2021
Q1 		$208M Sell
1,149,746
-132,515
-10% -$22.9M 0.67% 52
2020
Q4 		$182M Buy
+1,282,261
New +$186M 0.6% 63

Other funds holding TXG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management's TXG Position: Q1 2022 in Review

William Blair Investment Management sold out of 10x Genomics (TXG) in Q1 2022, closing a stake of 1,066,422 shares — an estimated $159M sold.

William Blair Investment Management first reported a position in TXG in Q4 2020 and held it in 5 quarters. The position peaked at $221M in Q2 2021. 314 funds tracked by Wall St. Rank hold TXG as of Q1 2022.

  • William Blair Investment Management reported no remaining 10x Genomics position as of Q1 2022 after selling out during the quarter.
  • William Blair Investment Management sold 1,066,422 10x Genomics shares in Q1 2022, an estimated $159M.
  • William Blair Investment Management first reported a position in 10x Genomics in Q4 2020 and held it in 5 quarters.
  • William Blair Investment Management's 10x Genomics position peaked at $221M in Q2 2021.
  • 314 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2022.

Based on William Blair Investment Management's 13F filing for Q1 2022, filed 11 May 2022.